Jess Hensley Lectureship
Presentation by Song Li, MD, PhD on Wednesday, December 13, at 1 pm in the Jess Hensley Library (BMS 433). Dr. Li's presentation is entitled "Multifuctional Nanocarriers for Improved Cancer Therapy." Dr. Li is Professor of Pharmaceutical Sciences in the Department of Pharmaceutical Sciences at the University of Pittsburg, PA. He is author or co-author of over 130 peer-reviewed articles and 30 review articles or book chapters. He is an Associate Editor for Journal of Gene Medicine and also serves on the editorial boards of a number of other journals. He frequently serves on NIH, DOD, and other study sections. Research in Dr. Li's lab has been continuously supported by NIH, DOD, and American Heart Association (AHA).
Babu A, Munshi A, Ramesh R. Combinatorial therapeutic approaches with RNAi and anticancer drugs using nanodrug delivery systems. Drug Dev Ind Pharm. 2017 May 19:1-11. doi: 10.1080/03639045.2017.1313861. [Epub ahead of print]. PMID: 28523942
Borre PV, Schrock AB, Anderson PM, Morris III JC, Heilmann AM, Holmes O, Wang K, Johnson A, Waguespack SG, Ou SI, Khan S, Fung KM, Stephens JP, Erlich RL, Miller VA, Ross JS, Ali SM. Pediatric, adolescent, and young adult thyroid carcinoma harbors frequent and diverse targetable genomic alterations, including kinase fusions. Oncologist 2017 Mar;22(3):255-263. doi: 10.1634/theoncologist.2016-0279. Epub 2017 Feb 16. PMID: 28209747
Cress WD, Yu P, Wu J. Expression and alternative splicing of the cyclin-dependent kinase inhibitor-3 gene in human cancer. Int J Biochem Cell Biol. Epub ahead of print 2017 May 11. doi.org/10.1016/j.biocel.2017.05.013. PMID: 28504190
Krais JJ, Virani N, McKenan PH, Nguyen Q, Fung KM, Sikavitsas VI, Kurkjian CD, Harrison RG. Antitumor synergism and enhanced survival with a tumor vasculature-targeted enzyme prodrug system, rapamycin, and cyclophosphamide. Mol Cancer Ther. 2017 May 18. pii: molcanther.0263.2016. doi: 10.1158/1535-7163.MCT-16-0263. [Epub ahead of print] PMID: 28522586
Rader JS, Sill MW, Beumer JH, Lankes HA, Benbrook DM, Garcia F, Trimble C, Tate Thigpen J, Lieberman R, Zuna RE, Leath CA, Spirtos NM, Byron J, Thaker P, Shashikant L, Alberts DA. Stratified randomized double-blind phase II trial of celecoxib for treating patients with cervical intraepithelial neoplasia: the predictive value of VEGF serum levels: an NRG Oncology/Gynecologic Oncology Group Study. Gynecol Oncol. 2017 May;145(2):291-297. doi: 10.1016/j.ygyno.2017.02.040. Epub 2017 Mar 10. PMID: 28285845
Shen T, Chen Z, Zhao ZJ, Wu J. Genetic defects of the IRF1-mediated major histocompatibility complex class I antigen presentation pathway occur prevalently in the JAK2 gene in non-small cell lung cancer. Oncotarget. Epub 2017 May 8. doi: 10.18632/oncotarget.17689. PMID: 28537924
Vuong HG, Altibi AMA, Duong UNP, Ngo HTT, Pham TQ, Fung KM, Hassell L. BRAF mutation is associated with an improved survival in glioma-a systematic review and meta-analysis. Mol Neurobiol. 2017 May 22. doi: 10.1007/s12035-017-0599-y. [Epub ahead of print] PMID: 28534272
Williams C, Akl P, Blick KE. Assessment of fetal lung maturity by lamellar body count in comparison to the fluorescence polarization TDx FLM-II and L/S ratio methods. J Neonatal Biol. 2017 May 16, 6: 256. doi: 10.4172/2167-0897.1000256.
McCall SJ, Dry S, Blond BJ, Souers RJ, Talbert ML, Tworek JA. Unsustainable? CAP survey of pathology directors highlights inconsistent support for tissue procurement. Poster presented at the International Society for Biological and Environmental Repositories Annual Meeting and Exhibitions, May 9-12, 2017, Toronto, Canada.
Pokala H, White J, Yu Z, Rivard D. Multifocal perivascular myoid tumor treated with cryoablation: a rare presentation and unique approach to treatment. Poster presented at the Annual Meeting of the American Society of Pediatric Hematology/Oncology. April 26-29, 2017, Montreal, Canada.
Welliver Sr R, Oomens A, Wolf R, Papin J, Ivanov V, Preno A, Staats R, Piedra P, Yu Z. M protein-deficient respiratory syncytial virus vaccine protects infant baboons against RSV challenge. Poster presented at the Annual Meeting of the Pediatric Academic Societies. May 6-9, 2017, San Francisco, CA.
BN Hannafon. Invited speaker. "MicroRNA Expression Signatures Predict Aggressiveness of Breast DCIS.” Breast Cancer Workshop: “Ductal Carcinoma in situ-Discerning Aggressive Versus Benign Disease Using Molecular Features.” American Society for Investigative Pathology 2017 Annual Meeting at Experimental Biology, April 22-26, 2017, Chicago, IL.
Hannafon BN, Gaskill K, Calloway C, Ding WQ. The role of metastasis-associated protein 1 (MTA1) in breast cancer exosome-mediated intercellular communication. Oral presentation at mini-symposium: “Mechanisms in Cancer.” American Society for Investigative Pathology 2017 Annual Meeting at Experimental Biology, April 22-26, 2017, Chicago, IL.
ML Talbert. Faculty, College of American Pathologists’ Laboratory Medical Direction Advanced Practical Pathology Program. April 20-21, 2017, Chicago, IL.
R Ramesh. Grant reviewer, Oklahoma IDeA Network of Biomedical Research Excellence Grant, April 24, 2017, OUHSC.
R Ramesh. Grant reviewer, Presbyterian Health Foundation Seed Grant for Established Investigators, April 21, 2017, OUHSC.
J Wu. NIH Tumor Cell Biology Study Section, June 8-9, 2017, Bethesda, MD.
Bethany Hannafon (PI). Exosome microRNAs as predictors of ductal carcinoma in situ progression. OCTSI Oklahoma Shared Clinical and Translational Resources Pilot Project.
Rajagopal Ramesh (PI). Nanotechnology and Biomimetics: Application in the Diagnosis, Imaging, Drug Delivery, and Treatment of Human Diseases. Presbyterian Health Foundation Symposium Grant.